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Objective: To present prenatal diagnosis and molecular cytogenetic characterization of a de novo 15q14
microdeletion associated with tetralogy of Fallot (TOF).
Materials and methods: This was the ﬁrst pregnancy of a 31-year-old primigravid woman. The pregnancy
was uneventful until 23 weeks of gestation when TOF was ﬁrst noted. The woman underwent amnio-
centesis at 23 weeks of gestation. Conventional cytogenetic analysis was performed using cultured
amniocytes and parental bloods. Array comparative genomic hybridization (aCGH) was performed on
uncultured amniocytes and parental bloods. Metaphase ﬂuorescence in situ hybridization (FISH) was
performed on cultured amniocytes. Quantitative ﬂuorescent-polymerase chain reaction (QF-PCR) anal-
ysis was performed on placental tissue and parental bloods.
Results: Conventional cytogenetics on cultured amniocytes revealed a karyotype of 46,XY, aCGH on
uncultured amniocytes revealed a de novo 4.858-Mb microdeletion in 15q14 encompassing ACTC1 and
MEIS2, and metaphase FISH analysis on cultured amniocytes conﬁrmed a 15q14 microdeletion. Postnatal
phenotype included facial dysmorphism. QF-PCR assays detected a paternal origin of the 15q14 micro-
deletion in the fetus.
Conclusion: Fetuses with 15q14 microdeletion may present TOF on the second-trimester ultrasound.
aCGH and metaphase FISH are useful for rapid prenatal diagnosis of 15q14 microdeletion associated with
TOF. A prenatal diagnosis of TOF should include a differential diagnosis of 15q14 microdeletion in
addition to 22q11.2 deletion syndrome and other microdeletion syndromes.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).s and Gynecology, MacKay
Road, Taipei 10449, Taiwan.
).
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Clinical reports concerning patients with deletion including the
cytogenetic band of 15q14 are very rare [1e17]. We previously re-
ported a male patient with speech and language disorder, cleft
palate, epilepsy, ventricular septal defect (VSD), mental retardation,
developmental delay and facial dysmorphism of low-set ears,by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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pointed chin and dental position abnormalities, and a 5.6-Mb
deletion in 15q14 (31,833,000e37,477,000 bp) [14]. Here, we
additionally present prenatal diagnosis and molecular cytogenetic
characterization of a de novo 4.858-Mb microdeletion in 15q14
(33,865,665e38,723,737 bp) associated with tetralogy of Fallot
(TOF) and facial dysmorphism. To our knowledge, this is the ﬁrst
report of prenatal diagnosis of 15q14 microdeletion because of
prenatal ultrasound abnormality of TOF. Our report emphasizes
that prenatal diagnosis of TOF should include a differential diag-
nosis of 15q14 microdeletion in addition to 22q11.2 microdeletion
syndrome and other microdeletion syndromes.
Materials and methods
Clinical description
This was the ﬁrst pregnancy of a 31-year-old woman. Her hus-
band was 50 years old, and there was no family history of
congenital malformations. The pregnancy was uneventful until
23 weeks of gestation when TOF was ﬁrst noted. The woman un-
derwent amniocentesis at 23 weeks of gestation. Conventional
cytogenetic analysis was performed using cultured amniocytes and
parental bloods. Array comparative genomic hybridization (aCGH)
was performed using uncultured amniocytes and parental bloods.
No cytogenetic abnormality was found by conventional cytoge-
netics. However, aCGH and metaphase ﬂuorescence in situ hy-
bridization (FISH) detected a 15q14 microdeletion. The male fetus
died at 26 weeks of gestation and postnatally manifested facial
dysmorphism of low-set ears, beaklike nose, prominent nasal
bridge, narrow forehead, long face, micrognathia and pointed chin,
a birth length of 34.5 cm, and a birth weight of 992 g. Quantitative
ﬂuorescent polymerase chain reaction (QF-PCR) was performed
using the DNA extracted from the placental tissue and the parental
blood samples to determine the parental origin of the de novo
deletion.
Conventional cytogenetic analysis
A routine cytogenetic analysis by G-banding techniques at the
550 bands of resolutionwas performed. Amniotic ﬂuid and parental
blood were collected, and the samples were subjected to cell cul-
ture according to the standard blood cytogenetic protocol.
aCGH
Whole-genome aCGH on the DNAs extracted from uncultured
amniocytes and parental bloods was performed using CytoChip
ISCA Array (Illumina, San Diego, CA, USA), which has 60,000 probes
and a median resolution of 51 kb across the entire genome ac-
cording to the manufacturer's instruction. The DNA from amnio-
cytes was extracted through the manufacturer's protocol of a
QIAamp DNA Mini kit (Qiagen, Inc., Valencia, CA, USA). Then,
0.65 mg of the extracted DNAwas labeled with Cy3 dye whereas the
same amount of normal female genomic DNA (gDNA, G1521;
Promega, Madison, WI, USA) was labeled in Cy5 dye as a control.
The experiment was performed according to the procedures rec-
ommended by the Illumina CytoChip Oligo Microarray Reference
Guide. The data were presented using BlueFuse Multi software
(Illumina, San Diego, CA, USA).
FISH
Metaphase FISH analysis was performed on cultured amniocytes
using a 15q14-speciﬁc bacterial artiﬁcial chromosome (BAC) probeRP11-815C16 (34,182,800e34,368,355) [hg 19] (FITC, green spec-
trum) and a 15q12-speciﬁc BAC probe RP11-812O7
(25,928,899e26,127,069) [hg 19] (Texas red, red spectrum) ac-
cording to the standard FISH protocol.
QF-PCR
QF-PCR analysis was performed on the DNA extracted from the
placental tissue and the parental bloods. Brieﬂy, primers specif-
ically ﬂanking short tandem repeat markers on chromosome 15
region such as D15S661 (15q11.1), D15S1232 (15q14), D15S194
(15q14), and D15S641 (15q15.1) were applied to undertake poly-
morphic marker analysis to determine the parental origin of
genomic imbalance if detected.
Results
The G-banded chromosome analysis revealed a karyotype of
46,XY in cultured amniocytes and normal karyotypes in parental
bloods. aCGH on the DNA extracted from the uncultured amnio-
cytes detected a de novo 4.858-Mb microdeletion in 15q14 or arr
15q14 (33,865,665e38,723,737) 1.0 (Figure 1). The deleted region
contains 54 genes including 17 OMIM genes of RYR3, AVEN, CHRM5,
KATNBL1, EMC4, SLC12A6, NOP10, NUTM1, LPCAT4, GOLGA8A, GOL-
GA8B, GJD2, ACTC1, AQR, C15orf41,MEIS2, and SPRED1. aCGH analysis
of the parental blood samples did not reveal such a deletion.
Metaphase FISH analysis showed the 15q14 microdeletion in 14/14
cultured amniocytes (Figure 2). QF-PCR assays detected a paternal
origin of the 15q14 microdeletion in the fetus (Figure 3).
Discussion
The present case had a 4.858-Mb microdeletion in 15q14
encompassing the cardiac development candidate genes of ACTC1
andMEIS2. Of interest is the association of 15q14microdeletion and
TOF on prenatal ultrasound in the present case. Congenital heart
defects associated with the cases with the 15q14 microdeletion
have been well described: Chen et al [14] reported VSD associated
with del(15)(q14) (submicroscopic, 5.6 Mb); Crowley et al [15] re-
ported VSD associated with del(15)(q14) (submicroscopic, 123 kb);
Johansson et al [17] reported VSD in three of nine cases with
del(15)(q14) (submicroscopic, 0.6e4.8 Mb); Brunetti-Pierri et al
[13] reported congenital heart defects associated with del(15)(q14)
(submicroscopic, 4.2 Mb) and del(15)(q13eq14) (submicroscopic,
8.9 Mb), respectively, in two patients; Erdogan et al [12] reported
atrial septal defect (ASD) associated with del(15)(q14) (submicro-
scopic, 5.3 Mb); Galan et al [8] reported pulmonary valve stenosis
associated with del(15)(q12eq14); Tonk et al [9] reported VSD,
patent ductus arteriosus (PDA), and ischemic cardiomyopathy
associated with del(15)(q12eq14); Autio et al [7] reported ASD
associated with del(15)(q13eq15); Herva and Vuorinen [3] re-
ported VSD, hypoplastic pulmonary artery, and atretic tricuspid
valve associated with del(15)(q12eq14); Pauli et al [5] reported
VSD associated with del(15)(pter-q15) and del(11)(q25-qter);
Windpassinger et al [10] reported persistent foramen ovale and
PDA associated with del(15)(pter-q14) and del(3)(qter); Duckett
and Roberts [4] reported VSD, ASD, PDA, and transposition of great
vessels associated with del(15)(pter-q14 or q15) and trisomy 13
(pter-q32 or q33); Schwartz et al [6] reported coarctation of the
aorta and PDA associated with del(15)(pter-q14) and del(22)(pter-
q13.2); and Matsumura et al [11] reported PDA associated with
del(15)(pter-q14) and trisomy 22q.
ACTC1 or actin, a-cardiac muscle (OMIM 102540) is identiﬁed
in muscle and has been suggested to be associated with
congenital heart defects. Matsson et al [18] performed ACTC1
Figure 1. Array comparative genomic hybridization of the DNA extracted from the uncultured amniocytes shows a 4.858-Mb microdeletion in 15q14 or arr 15q14
(33,865,665e38,723,737)  1.0. The deleted region contains the genes of ACTC1 and MEIS2. (A) Whole genome view. (B and C) Zoom-in view.
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atrial septa and suggested a-cardiac actin mutations produce
ASDs. Heterozygous mutations in the ACTC1 gene have been
associated with dilated cardiomyopathy 1R (CMD1R) (OMIM
613424), hypertrophic cardiomyopathy 11 (CMH11) (OMIM
612098), left ventricular noncompaction 4 (LVNC4) (OMIM
613424), and atrial septal defect 5 (ASD5) (OMIM 612794).Matsson et al [18] analyzed two large Swedish families segre-
gating autosomal dominant secundum ASD5 and identiﬁed het-
erozygosity for a mutation of M123V in the 20 affected
individuals. Matsson et al [18] also identiﬁed a 17-bp deletion in
the ACTC1 gene in a 10-year-old girl with secundum ASD.
MEIS2 or myeloid ectopic viral insertion site, mouse homolog of,
2 (OMIM 601740) is a homeodomain-containing transcription
Figure 2. Metaphase ﬂuorescence in situ hybridization on the cultured amniocytes
using a 15q14-speciﬁc bacterial artiﬁcial chromosome (BAC) probe RP11-815C16
(34,182,800e34,368,355) [hg 19] (FITC, green spectrum) and a 15q12-speciﬁc BAC
probe RP11-812O7 (25,928,899e26,127,069) [hg 19] (Texas red, red spectrum) shows
both red and green signals in the normal chromosome 15 (chr15) and only the red
signal in the aberrant chromosome 15 or del(15).
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ciated with congenital heart defects and cleft palate [12,13,15e22].
Stankunas et al [19] demonstrated that in the mice model,
disruption of MEIS, which encodes a Pbx DNA-binding partner,Figure 3. Representative electrophoretograms of quantitative ﬂuorescent-polymerase chain
informative markers D15S1232 (15q14) and D15S194 (15q14) show only one peak of ﬂuore
15q14 microdeletion in the fetus.results in a full spectrum of cardiac anomalies involving the outﬂow
tract resembling those caused by mutations of Pbx genes. Crowley
et al [15] reported a male infant with cleft palate, VSD, bilateral
hearing loss, and a mosaic deletion of a 123-kb region
(34,978,029e35,100,886) encompassing only the MEIS2, and sug-
gested that MEIS2 is involved in the development of congenital
heart defects and cleft palate. Paige et al [20] demonstrated that in
the zebraﬁsh model, MEIS2 is critical for proper heart tube forma-
tion and subsequent cardiac looping. Johansson et al [17] suggested
that in syndromic cases of congenital heart defects and orofacial
clefting,MEIS2 should be considered among the candidate genes in
cases without 22q11.2 deletions. Louw et al [21] reported a de novo
small intragenic mutation in MEIS2 in a female patient with cleft
palate, septal defects, aortic coarctation, facial dysmorphism, in-
tellectual disability, and autism spectrum disorder, and suggested
that MEIS2 is involved in cardiac development, cleft palate, and
intellectual disability. Machon et al [22] demonstrated that MEIS2
plays a critical role during cranial and cardiac neural crest cell
development in the mouse.
In the present case, the conventional cytogenetic analysis of
cultured amniocytes revealed a karyotype of 46,XY, whereas aCGH
analysis on uncultured amniocytes andmetaphase FISH analysis on
cultured amniocytes revealed a 15q14 microdeletion. The aCGH
analysis on uncultured amniocytes has the advantage of detection
of microdeletion syndromes in the fetuses with a normal karyotype
by conventional cytogenetic analysis [23,24].
Patients with 22q11.2 deletion syndrome are associated with a
high rate of congenital heart defects, especially conotruncal mal-
formations, TOF, interrupted aortic arch, VSD, and truncus arte-
riosus, as well as a high rate of palatal malformations. However,
various chromosomal loci and genes have been responsible for
congenital heart defects and TOF in addition to TBX1 (22q11.2;
OMIM 602054) such as CFC1 (2q21.1; OMIM 605194), NKX2-5reaction assays on the DNA extracted from placental tissue and parental bloods. The
scent activity from the maternal allele in the fetus, indicating a paternal origin of the
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(8q23.1; OMIM 603693), GATA6 (18q11.2; OMIM 601656), GDF1
(19p13.11; OMIM 602880), and JAG1 (20p12.2; OMIM 601920) [25].
The present case provides evidence that fetuses with 15q14
microdeletion may present TOF on the second-trimester ultra-
sound. We suggest that prenatal diagnosis of TOF should include a
differential diagnosis of 15q14 microdeletion in addition to 22q11.2
microdeletion syndrome and other microdeletion syndromes.
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